United Natural Foods, ABM Industries and 3 Stocks to Watch Heading Into Tuesday

Benzinga Earnings
Sep 08

With U.S. stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

  • Wall Street expects United Natural Foods Inc. (NYSE:UNFI) to report quarterly earnings of 61 cents per share on revenue of $7.68 billion before the opening bell, according to data from Benzinga Pro. United Natural Foods shares gained 1.4% to $44.54 in after-hours trading.
  • Novartis AG (NYSE:NVS) disclosed that the pelacarsen phase III Lp(a) HORIZON trial did not meet its primary endpoint. Novartis shares dipped 4.7% to $152.50 in the after-hours trading session.
  • Analysts are expecting ABM Industries Inc. (NYSE:ABM) to post quarterly earnings of $1.01 per share on revenue of $2.31 billion. The company will release earnings before the markets open. ABM shares fell 0.1% to $47.02 in after-hours trading.

Check out our premarket coverage here

  • Co-Diagnostics Inc. (NASDAQ:CODX) announced the departure of its CFO Brian Brown. The company named Daniel Bohrer as principal financial officer. Co-Diagnostics shares gained 1.7% to $1.18 in the after-hours trading session.
  • Analysts expect Casey’s General Stores Inc. (NASDAQ:CASY) to post quarterly earnings of $6.75 per share on revenue of $5.57 billion after the closing bell. Casey’s shares fell 0.3% to close at $756.09 on Friday.

Photo via Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10